During the past decade, Ospedale San Giuseppe conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale San Giuseppe" are "Colorectal Cancer" (1 trials), "Device Replacement" (1 trials), "Device Upgrade" (1 trials), "Diamond Blackfan Anemia" (1 trials) and "Long-term Postoperative Complications" (1 trials). Many other conditions were trialed in "Ospedale San Giuseppe" in a lesser frequency.

Most popular intervention types in "Ospedale San Giuseppe" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferasirox" (1 trials), "bevacizumab" (1 trials), "fluorouracil" (1 trials), "irinotecan hydrochloride" (1 trials) and "leucovorin calcium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale San Giuseppe" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale San Giuseppe". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale San Giuseppe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale San Giuseppe, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".